SCHEMBL14359786

SCHEMBL14359786

OC[C@@H]1CCC[C@H](F)[C@H]1O

nearest known ligand 0.33

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.33
GBA1 P04062 7/20 0.32
SI P14410 1/20 0.32
PYGL P06737 1/20 0.32
GBA2 Q9HCG7 1/20 0.32
GAA P10253 1/20 0.32
GLB1 P16278 1/20 0.32
PABPC1 P11940 1/20 0.31
APOBEC3A P31941 1/20 0.31
APOBEC3G Q9HC16 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL259151 0.85
SCHEMBL14949083 0.82 TDP1 (0.39) TDP1GBA1SIPYGLGBA2
SCHEMBL14211655 0.77
SCHEMBL22914943 0.77
SCHEMBL18332300 0.76
SCHEMBL21783304 0.75 GBA1 (0.44) TDP1GBA1SIPYGLGBA2
SCHEMBL7100318 0.75 GBA1 (0.44) TDP1GBA1SIPYGLGBA2
SCHEMBL924500 0.73
SCHEMBL1802277 0.73
SCHEMBL4141863 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2726468-A1 SELECTIVE GLYCOSIDASE INHIBITORS AND USES THEREOF Alectos Therapeutics Inc. (CA) 2014-05-07 EP disclosed
WO-2013000085-A1 SELECTIVE GLYCOSIDASE INHIBITORS AND USES THEREOF ALECTOS THERAPEUTICS INC. (CA) 2013-01-03 WO disclosed